Primary Angle Closure Glaucoma and Aqueous Dynamics

Sponsor
Guy's and St Thomas' NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT00719290
Collaborator
(none)
24
1
2
85
0.3

Study Details

Study Description

Brief Summary

The aim of the study is to determine which is the best treatment for people with cataract and primary angle closure (PAC).In PAC, apposition of the iris tissue to the drainage channels (Trabecular Meshwork-TM) of the eye results in damage and formation of adherences between these structures (Peripheral anterior synaechiae-PAS) causing a mechanical obstruction of the aqueous outflow via the TM. It is thought that cataract surgery combined with mechanical separation of the iris from the TM with the breakage of PAS(we call this separation 'goniosynechialysis') would make the pressure even lower as it would cause the drain to open to a greater extent than cataract surgery alone. This technique is not new, and the results have been very encouraging. Comparing this technique to cataract surgery alone however, has not been done and this is exactly what we would like to do in order to help us decide what is the best treatment.

In summary, the investigators propose that cataract surgery with goniosynechialysis would lower intraocular pressure to a greater extent than cataract surgery alone in patients with significant PAS.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Phacoemulsification (Acrylic Foldable Intraocular Lens (Acrysoft)), (Healon5)
  • Procedure: Phacoemulsification and goniosynechialysis (Acrylic Foldable Intraocular Lens (Acrysoft)), (Healon5)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
A Randomised Comparative Study of the Effects of Cataract Extraction With Lens Implant Alone Versus Cataract Extraction With Lens Implant and Goniosynechialysis on Outflow Facility in Patients With Primary Angle Closure Glaucoma.
Study Start Date :
Jul 1, 2008
Actual Primary Completion Date :
Aug 1, 2015
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Phacoemulsification with intraocular lens implant alone

Procedure: Phacoemulsification (Acrylic Foldable Intraocular Lens (Acrysoft)), (Healon5)
Phacoemulsification of the lens with intraocular lens implant
Other Names:
  • Healon5
  • Acrylic Foldable Intraocular Lens (Acrysoft)
  • Active Comparator: 2

    Phacoemulsification with intraocular lens implant and goniosynechialysis

    Procedure: Phacoemulsification and goniosynechialysis (Acrylic Foldable Intraocular Lens (Acrysoft)), (Healon5)
    Phacoemulsification of the lens with intraocular lens implant and goniosynechialysis
    Other Names:
  • Healon5
  • Acrylic Foldable Intraocular Lens (Acrysoft)
  • Outcome Measures

    Primary Outcome Measures

    1. 1. Outflow facility Success defined as increased outflow facility at 3 month compared to baseline with the same or reduced number of intraocular pressure lowering medications. [3 months]

    Secondary Outcome Measures

    1. 1. Intraocular pressure Success defined as decreased IOP at 3 month compared to baseline with the same or reduced number of intraocular pressure lowering medications [3 months]

    2. Intra- or post operative complications [2-3 weeks]

    3. Long-term PAS development [1 year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age ≥ 21 years.

    • Diagnosis of PAC or PACG. PACG is defined as glaucomatous optic neuropathy in the opinion of a fellowship-trained glaucoma specialist, together with an IOP > 21mmHg on at least one occasion, and reproducible visual field defect (using the 24-2 test pattern on a Humphrey Field Analyser). PAC has all the above characteristics except for the visual field defect.

    • More than 90 degrees of PAS (not necessarily contiguous).

    • Lens opacity deemed sufficient to be causing decreased vision in the opinion of the supervising consultant (KSL).

    • Ability to give informed consent.

    Exclusion Criteria:
    • Previous intraocular surgery or keratorefractive surgery.

    • Previous eye trauma resulting in documented damage to the drainage angle (such as angle recession).

    • History of uveitis.

    • For patients on warfarin, INR >3.0 on day of surgery.

    • Anterior segment neovascularisation.

    • Chronic use of topical or systemic steroids.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St Thomas' Hospital London United Kingdom SE1 7EH

    Sponsors and Collaborators

    • Guy's and St Thomas' NHS Foundation Trust

    Investigators

    • Principal Investigator: K Sheng Lim, MB ChB MD FRCOpht, Guys ans St Thomas' NHS Trust

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    KIN SHENG LIM, Consultant Ophthalmic Surgeon, Guy's and St Thomas' NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT00719290
    Other Study ID Numbers:
    • RJ1 08/0124
    First Posted:
    Jul 21, 2008
    Last Update Posted:
    Aug 19, 2015
    Last Verified:
    Aug 1, 2015
    Keywords provided by KIN SHENG LIM, Consultant Ophthalmic Surgeon, Guy's and St Thomas' NHS Foundation Trust
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 19, 2015